Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis (TMC207-CL001)

Clinical trial NCT01215110 · COMPLETED

Trial details

NCT number: NCT01215110
Sponsor: Global Alliance for TB Drug Development
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pulmonary Tuberculosis

Start date: 2010-04-01
Primary completion: 2010-08-01
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.